Exploring the Frontiers of Innovation to Tackle Microbial Threats Proceedings of a Workshop (2020) / Chapter Skim
Currently Skimming:
8 Visionary Statements on Priorities for Innovation
8 Visionary Statements on Priorities for Innovation
Pages 117-124
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 117... ...
. Moderated by Marcos Espinal, director, Department of Communicable Diseases and Environmental Determinants of Health, Pan American Health Organization, the panelists synthesized priority actions on cultivating innovative solutions to address emerging microbial threats that are sustainable, ethical, equitable, and focused on interventions that most effectively improve people's lives.
|
From page 118... ...
To address visceral leishmaniasis, researchers are implementing more than 2 million insecticide-impregnated dog collars in the regions of Brazil heavily affected by the disease. Finally, he noted that a prison-based tuberculosis intervention is being implemented, because mathematical modeling suggests that exit screening is more effective than entry screening to detect the spread of the disease in prisons and to reduce the spillover effect in the general community (Mabud et al., 2019)
|
From page 119... ...
For instance, an innovation is being piloted in Britain in a "Netflix-style" subscription model, whereby companies would develop antibiotics, and the hospitals and health care systems would pay into a subscription model in order to have access to those drugs if they need them. Another example is the nonprofit model used by Canadian Blood Services, which sends tenders out to companies to purchase large lots of factor VIII and factor IX, so that hospitals can directly request the products from Canadian Blood Services when they are needed, rather than requiring individual hospitals to procure the products themselves.
|
From page 120... ...
INNOVATIONS TO MAXIMIZE IMPACT IN AIDS, TUBERCULOSIS, AND MALARIA Peter Sands explained that his organization is the largest multinational funding vehicle in global health, with an unprecedented $14 billion to spend through 2023. The Global Fund is not interested in innovation for innovation's sake, he said.
|
From page 121... ...
Most of the organization's funding will be committed in signed grants for programs by the end of 2020, and the innovators with whom they work most successfully have a deep understanding of The Global Fund's mechanisms. He noted that progress moves slowly in the health world, for many good reasons, but suggested that there may be room for greater focus on the "time value of money" measured in lives (e.g., the lives lost due to lengthy delays in changing treatment guidelines for tuberculosis and HIV to incorporate new and improved regimens)
|
From page 122... ...
Finding ways to use technology to support community health workers could help reduce their paperwork burden. He said that innovation in financing models would benefit countries with large informal economies where traditional tax or insurance modes of financing health do not work well.
|
From page 123... ...
is effective in addressing the diseases and building local capacities simultaneously, he said. Audrey Lenhart asked about the level of evidence that would be sufficient to justify scaling up innovative interventions nationwide, such as the Wolbachia intervention in Brazil or the malaria vector control interventions supported by The Global Fund.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.